Pearl IRB was featured in the August 21st weekly print publication and on the web. See below for an excerpt: “Before the first volunteer takes a needle in the arm to test an experimental drug, the proposed clinical trial must first be vetted by a panel of...
Pearl IRB’s own Gretchen Bowker, Chief Operating Officer, will present an overview of the requirements and regulations surrounding IRB reviews on September 23, 2010. The meeting will be held over dinner at University of Indianapolis, 5:30-8pm. To sign up,...
Have you seen the OHRP training videos on YouTube? What a great idea; and with an average of a 1,000 views, I guess many of you agree. It’s a great way to train new board members, PIs and the community about human research. The topics cover IRB membership, Informed...
Pearl IRB is pleased to launch it’s whitepaper entitled “Trends and Insights in IRB Warning Letters.” Learn all about IRB warning letters issued by the FDA, review the issues, and learn how to protect yourself from violations. Click here to...
August 2, 2010 Pearl IRB releases news about their role in fostering clinical trials in Indiana and beyond. Check out the full release, read a quote provided by Kristin Jones, President of Indiana Health Industry Forum and more. Read more.
Ethics of Safety Studies for Marketed Drugs Even the Average Joe couldn’t have missed the discussions regarding the safety risks of Avandia. FDA is again in a tough spot and looking for answers. Traditionally, Industry was not to make safety claims about drugs, just...
